SALL4 and myelodysplastic syndrome: On the other hand, methylation-specific PCR (MSP) has validated aberrant hypomethylation of SALL4 promoter in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients [15,27].